BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36849257)

  • 1. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
    Augostini P; Bradley ELP; Raphael BH; Secor WE
    Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
    Crowell AL; Sanders-Lewis KA; Secor WE
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
    Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
    Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of amixicile against T. vaginalis from clinical isolates.
    Jain E; Zaenker EI; Hoffman PS; Warren CA
    Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
    Müller M; Lossick JG; Gorrell TE
    Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole.
    Biagi M; Slipke W; Smalley A; Tsaras G
    Int J STD AIDS; 2021 Jan; 32(1):89-91. PubMed ID: 33121364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.
    Meingassner JG; Thurner J
    Antimicrob Agents Chemother; 1979 Feb; 15(2):254-7. PubMed ID: 311617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
    Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
    Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
    Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
    J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010.
    Kirkcaldy RD; Augostini P; Asbel LE; Bernstein KT; Kerani RP; Mettenbrink CJ; Pathela P; Schwebke JR; Secor WE; Workowski KA; Davis D; Braxton J; Weinstock HS
    Emerg Infect Dis; 2012 Jun; 18(6):939-43. PubMed ID: 22608054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.